Industry Updates

#Pharmaceutical & Drug Discovery

Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia
OXFORD, England and OSAKA, Japan, March 22, 2019 /PRNewswire/ -- Exscientia, the world-leading Artificial Intelligence (AI)-driven drug discovery company announces the establishment of a subsidiary, Exscientia K.K to spearhead its pharmaceutical interests ...
Read more

Global Drug Discovery Market 2019-2024: Rising Healthcare Expenditure, and Upcoming Patent Expiration of Blockbuster Drugs
Thus, owing to the large deals of pharmaceutical companies and more number of research being done, the market for drug discovery is expected to grow. The market studied has various pharmaceutical companies that are investing billions of dollars in ...
Read more

Celgene taps Exscientia’s AI drug discovery tech for 3 new programs
Exscientia is adding another Big Pharma to its list of partners. This time, the drug discovery specialist is teaming up with Celgene on three programs in oncology and autoimmunity. Celgene is handing over a $25 million upfront payment, as well as promising ...
Read more

Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
OSAKA, Japan & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Mar 18, 2019--Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced ...
Read more

Machine learning scientists to collaborate on AI-powered drug discovery
The applications of AI in drug discovery are very broad and can be classified into several areas: The advent of artificial intelligence in the pharmaceutical industry is expected to enable the countries that did not previously engage in early-stage drug ...
Read more

Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
Suneja said Biogen has about $42 billion in financing capacity and identified potential acquisition targets such as Sage Therapeutics Inc , GW Pharmaceuticals (GWPH.O) and Zogenix Inc that are ...
Read more

Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases
HemoShear's drug discovery platform, REVEAL-Tx™, enables the ... with Takeda and in gout with Horizon Pharma. For more information visit www.HemoShear.com About HemoShear's REVEAL-Tx™ PlatformExisting human experimental disease models do not ...
Read more

Ono Pharmaceutical, twoXAR Collaborate on Drug Discovery Research
On March 18, 2019, Ono Pharmaceutical, a Japanese pharmaceutical R&D company, and twoXAR, an artificial intelligence (AI)-focused biopharmaceutical company, announced that the companies have signed a drug discovery research collaboration to jointly ...
Read more

World Drug Discovery and Therapy Congress Conference 2019 - Corporate (Boston, United States - September 3-5, 2019)
At the 2019 congress, the major topics of discussion related to drug, discovery and therapy will include: Pharmaceutical Research & Development, Translational Medicine, Regenerative Medicine, Enabling Technologies, Structural Biology, Drug Delivery ...
Read more

Dr. Nir Barzilai to present at the 6th Aging Research for Drug Discovery Forum in Basel
In addition to working collaborations with the large pharmaceutical companies, the company is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia ...
Read more